Firefly Neuroscience (NASDAQ:AIFF) Announces Earnings Results

Firefly Neuroscience (NASDAQ:AIFF) announced its earnings results on Tuesday. The company reported ($0.07) earnings per share for the quarter, FiscalAI reports. The business had revenue of $0.65 million for the quarter. Firefly Neuroscience had a negative return on equity of 90.17% and a negative net margin of 506.23%.

Firefly Neuroscience Price Performance

Shares of AIFF stock traded up $0.05 during trading hours on Wednesday, reaching $1.02. 28,293 shares of the company’s stock were exchanged, compared to its average volume of 3,865,514. The company’s 50 day moving average is $1.14 and its two-hundred day moving average is $1.35. The company has a market cap of $16.07 million, a P/E ratio of -1.73 and a beta of 0.49. Firefly Neuroscience has a 1 year low of $0.62 and a 1 year high of $3.15.

Wall Street Analysts Forecast Growth

AIFF has been the topic of a number of analyst reports. Wall Street Zen lowered Firefly Neuroscience from a “hold” rating to a “sell” rating in a research report on Saturday, August 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Firefly Neuroscience in a report on Friday, August 14th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, Firefly Neuroscience has an average rating of “Sell”.

Institutional Trading of Firefly Neuroscience

A hedge fund recently raised its position in Firefly Neuroscience stock. Cygnus Capital Advisors LLC boosted its position in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 122.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 44,552 shares of the company’s stock after purchasing an additional 24,513 shares during the quarter. Cygnus Capital Advisors LLC owned approximately 0.28% of Firefly Neuroscience worth $54,000 at the end of the most recent reporting period. Institutional investors own 4.96% of the company’s stock.

Firefly Neuroscience Company Profile

Firefly Neuroscience, Inc. is a digital health and neuroscience company focused on using artificial intelligence to support the assessment and treatment of brain disorders. The company develops technology designed to analyze electroencephalography (EEG) data and identify patterns associated with cognitive and psychiatric conditions. Its principal platform, Brain Network Analytics (BNA), is intended to convert EEG recordings into clinically relevant measures of brain function. Firefly’s technology is designed to help healthcare professionals evaluate conditions such as Alzheimer’s disease and major depressive disorder, monitor changes in patients’ brain activity, and support more personalized treatment decisions.